Ilex Capital Partners’s Chemours CC Stock Holding History

Ilex Capital Partners’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,482	Closed	-$229K	–	84
2025 Q3	$229K	Buy	+14,482	New	+$210K	0.01%	130

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ilex Capital Partners's CC Position: Q4 2025 in Review

Ilex Capital Partners sold out of Chemours (CC) in Q4 2025, closing a stake of 14,482 shares — an estimated $229K sold.

Ilex Capital Partners first reported a position in CC in Q3 2025 and held it in 1 quarter. The position peaked at $229K in Q3 2025. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

Ilex Capital Partners reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
Ilex Capital Partners sold 14,482 Chemours shares in Q4 2025, an estimated $229K.
Ilex Capital Partners first reported a position in Chemours in Q3 2025 and held it in 1 quarter.
Ilex Capital Partners's Chemours position peaked at $229K in Q3 2025.
435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Ilex Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.